Medical management of prostatic hyperplasia

Creating IPR and design value.

Medical device technology·2004

Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery.

The Journal of pharmacology and experimental therapeutics·1996

[Terazosine in the treatment of benign prostatic hypertrophy].

Journal d'urologie·1993

Antispasmodic effects of flavoxate, MFCA, and REC 15/2053 on smooth muscle of human prostate and urinary bladder.

Urology·1991

Triorchidism--a reconstructive approach.

Urology·1990

Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.

The Urologic clinics of North America·1990

Heparin-induced thrombocytopenia and thrombosis.

Comprehensive therapy·2011

Antiplatelet therapy in cardiovascular disease.

Comprehensive therapy·2011

Genetics of cardiovascular disease.

Comprehensive therapy·2011

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Comprehensive therapy·2011

Gout and hyperuricemia.

Comprehensive therapy·2011

Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.

Comprehensive therapy·2010

Indications for repeated computed tomography after mild traumatic brain injury with intracranial haemorrhage.

Danish medical journal·2026

Anterior versus posterior peroral endoscopic myotomy: a prospective randomized controlled trial from a Thai tertiary center.

Clinical endoscopy·2026

Subbrow Blepharoplasty to Augment Blepharoptosis Repair in East Asian Patients.

Plastic and reconstructive surgery. Global open·2026

BK Polyomavirus-Associated Urothelial Carcinoma Presenting as Obstructive Uropathy in a Long-Term Lung Transplant Recipient.

Cureus·2026

Dual attitudes toward doctors: the role of shared decision-making and empathy in frustrated medical treatment in a randomized trial.

Frontiers in public health·2026

The treatment with or without prednisolone in adults aged ≥ 70 years with myasthenia gravis: a retrospective cohort study.

Frontiers in neurology·2026

Related Experiment Videos

Medical management of prostatic hyperplasia

Related Concept Videos

Creating IPR and design value.

Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery.

[Terazosine in the treatment of benign prostatic hypertrophy].

Antispasmodic effects of flavoxate, MFCA, and REC 15/2053 on smooth muscle of human prostate and urinary bladder.

Triorchidism--a reconstructive approach.

Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.

Heparin-induced thrombocytopenia and thrombosis.

Antiplatelet therapy in cardiovascular disease.

Genetics of cardiovascular disease.

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Gout and hyperuricemia.

Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.

Indications for repeated computed tomography after mild traumatic brain injury with intracranial haemorrhage.

Anterior versus posterior peroral endoscopic myotomy: a prospective randomized controlled trial from a Thai tertiary center.

Subbrow Blepharoplasty to Augment Blepharoptosis Repair in East Asian Patients.

BK Polyomavirus-Associated Urothelial Carcinoma Presenting as Obstructive Uropathy in a Long-Term Lung Transplant Recipient.

Dual attitudes toward doctors: the role of shared decision-making and empathy in frustrated medical treatment in a randomized trial.

The treatment with or without prednisolone in adults aged ≥ 70 years with myasthenia gravis: a retrospective cohort study.

Related Experiment Videos

Medical management of prostatic hyperplasia

Related Concept Videos

Related Articles